Science Explorer Back to mapMap
Discussion
Researcher · Novartis (Switzerland) · Switzerland

David Lebwohl

David Lebwohl publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies and PI3K/AKT/mTOR signaling in cancer.

ORCID 0000-0002-4578-1977 OpenAlex
World rank
#121,427
of 7,710,434 ranked researchers
Rank in Switzerland
#2,526
of 80,918
Works
90
Citations
28k
Citations per work
308.7
h-index
44
i10-index 71Top 5.1% in Oncology
David Lebwohl

What does David Lebwohl research?

David Lebwohl's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (26%).

Health Sciences: 42 works · 47.1% of their workMedicine: 42 works · 47.1% of their workOncology: 24 works · 26.5% of their workPulmonary and Respiratory Medicine: 12 works · 12.8% of their workPhysiology: 4 works · 4.3% of their workHematology: 3 works · 3.5% of their workEverything else: 24 works · 27.2% of their workLife Sciences: 23 works · 25.7% of their workBiochemistry, Genetics and Molecular Biology: 23 works · 25.7% of their workMolecular Biology: 16 works · 17.5% of their workCancer Research: 7 works · 8.2% of their workTHEIR WORKDavid Lebwohl90works
Life Sciences26%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4247.1%
  2. Everything else2427.2%
    1. Biochemistry, Genetics and Molecular Biology2325.7%
  1. 1Oncology26% of their works
  2. 2Molecular Biology18% of their works
  3. 3Pulmonary and Respiratory Medicine13% of their works
  4. 4Cancer Research8% of their works
  5. 5Physiology4% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe David Lebwohl's research?

The keywords of their largest research topics: Metastatic Breast Cancer, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Molecular Subtypes, Genetic Mutations, Cetuximab, KRAS Mutations and mTOR.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Metastatic Breast Cancer352 topics
  2. Chemotherapy-Induced Peripheral Neuropathy271 topic
  3. Taxanes271 topic
  4. Molecular Subtypes232 topics
  5. Genetic Mutations172 topics
  6. Cetuximab141 topic
  7. KRAS Mutations141 topic
  8. Signaling111 topic
  9. mTOR111 topic
  10. VEGF101 topic
  11. endothelial progenitor cells101 topic
  12. Breast Tumours91 topic
  13. Gene Expression91 topic
  14. Metastatic91 topic
  15. Renal Cell Carcinoma91 topic
  16. Breast Cancer81 topic
  17. CDK4/6 Inhibitors81 topic
  18. Lymphangioleiomyomatosis81 topic
  19. Tuberous Sclerosis Complex81 topic

Where does David Lebwohl work?

David Lebwohl's main affiliation in the publication record is Novartis (Switzerland), Switzerland.

How many publications and citations does David Lebwohl have?

OpenAlex counts 90 works and 27,785 citations for David Lebwohl, an h-index of 44, ranking #121,427 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David Lebwohl. Posts are plain text and can be reported.